VTGN - VistaGen Therapeutics, Inc.
NASDAQ
->
Healthcare
->
Biotechnology
South San Francisco,
United States
Type: Equity
VTGN price evolution
VTGN
| (in millions $) | 1 May 2025 | 31 Jan 2025 | 30 Oct 2024 | 30 Jul 2024 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $102.92 | |||
| Short term investments | $5.45 | |||
| Net receivables | ||||
| Inventory | ||||
| Total current assets | $99.95 | $110.84 | ||
| Long term investments | ||||
| Property, plant & equipment | $2.05 | $2.19 | ||
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $2.71 | |||
| Total investments | $5.45 | |||
| Total assets | $102.5 | $113.55 | ||
| Current liabilities | ||||
| Accounts payable | $0.71 | $1.21 | ||
| Deferred revenue | $3.38 | |||
| Short long term debt | $0.57 | |||
| Total current liabilities | $7.52 | $6.24 | ||
| Long term debt | $1.42 | |||
| Total noncurrent liabilities | $2.51 | |||
| Total debt | $1.99 | |||
| Total liabilities | $9.52 | $8.74 | ||
| Shareholders' equity | ||||
| Retained earnings | -$379.91 | -$366.95 | ||
| Other shareholder equity | $0.02 | $0 | ||
| Total shareholder equity | $104.8 | |||
| (in millions $) | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $119.17 | $16.64 | $68.14 | $103.11 |
| Short term investments | ||||
| Net receivables | $0.27 | $0.04 | ||
| Inventory | ||||
| Total current assets | $120.67 | $17.51 | $71 | $104.12 |
| Long term investments | ||||
| Property, plant & equipment | $2.25 | $2.77 | $3.08 | $3.59 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $2.98 | $3.58 | $3.65 | $4.16 |
| Total investments | ||||
| Total assets | $123.65 | $21.09 | $74.64 | $108.28 |
| Current liabilities | ||||
| Accounts payable | $1.55 | $2.47 | $2.76 | $0.84 |
| Deferred revenue | $3.46 | $3.03 | $2.8 | $3.91 |
| Short long term debt | $0.55 | $0.59 | $0.43 | $0.37 |
| Total current liabilities | $5.12 | $4.57 | $5.77 | $4.19 |
| Long term debt | $1.57 | $2.13 | $2.61 | $3.35 |
| Total noncurrent liabilities | $4.24 | $4.44 | $4.16 | $12.11 |
| Total debt | $2.12 | $2.72 | $3.04 | $3.72 |
| Total liabilities | $9.37 | $9.01 | $9.93 | $16.3 |
| Shareholders' equity | ||||
| Retained earnings | -$356.21 | -$326.85 | -$267.6 | -$219.84 |
| Other shareholder equity | ||||
| Total shareholder equity | $114.29 | $12.08 | $64.72 | $91.98 |
| (in millions $) | 30 Jul 2025 | 31 Jan 2025 | 30 Oct 2024 | 30 Jul 2024 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | ||||
| Cost of revenue | ||||
| Gross Profit | ||||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | ||||
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | ||||
| Interest expense | ||||
| Net income | ||||
| Net income | ||||
| Income (for common shares) | ||||
| (in millions $) | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1.06 | -$0.23 | $1.11 | $1.09 |
| Cost of revenue | ||||
| Gross Profit | $1.06 | -$0.23 | $1.11 | $1.09 |
| Operating activities | ||||
| Research & development | $20.02 | $44.38 | $35.41 | $12.48 |
| Selling, general & administrative | $14.06 | $14.66 | $13.48 | $6.55 |
| Total operating expenses | $34.09 | $59.04 | $48.89 | $19.02 |
| Operating income | -$33.02 | -$59.27 | -$47.78 | -$17.93 |
| Income from continuing operations | ||||
| EBIT | -$29.36 | -$59.24 | -$47.76 | -$17.93 |
| Income tax expense | $0 | $0.01 | $0 | $0 |
| Interest expense | ||||
| Net income | ||||
| Net income | -$29.36 | -$59.25 | -$47.76 | -$17.93 |
| Income (for common shares) | -$29.36 | -$59.25 | -$48.71 | -$42.32 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$10.73 | -$9.52 | -$6.35 | |
| Operating activities | ||||
| Depreciation | $0.15 | $0.15 | $0.14 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $1.16 | $0.52 | $0.51 | |
| Total cash flows from operations | -$10.87 | -$7.2 | -$4.54 | |
| Investing activities | ||||
| Capital expenditures | -$0.04 | -$0.03 | -$0.03 | |
| Investments | -$5.42 | |||
| Total cash flows from investing | -$13.25 | -$5.47 | -$0.03 | -$0.03 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.09 | -$0.17 | $93.52 | |
| Net borrowings | $0 | -$0 | ||
| Total cash flows from financing | $0.09 | $0.09 | -$0.17 | $93.52 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$34.92 | -$16.25 | -$7.39 | $88.95 |
| (in millions $) | 31 Dec 2024 | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Net income | -$29.36 | -$59.25 | -$47.76 | -$17.93 |
| Operating activities | ||||
| Depreciation | $0.57 | $0.53 | $0.71 | $0.12 |
| Business acquisitions & disposals | -$0.53 | |||
| Stock-based compensation | $2.18 | $3.34 | $3.48 | $2.31 |
| Total cash flows from operations | -$25.81 | -$49.72 | -$45.26 | -$12.07 |
| Investing activities | ||||
| Capital expenditures | -$0.06 | -$0.21 | -$0.2 | -$0.28 |
| Investments | ||||
| Total cash flows from investing | -$0.06 | -$0.74 | -$0.2 | -$0.28 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $129.39 | -$0.01 | $10.49 | $114.48 |
| Net borrowings | -$0.98 | -$1.04 | -$0 | -$0.38 |
| Total cash flows from financing | $128.4 | -$1.04 | $10.48 | $114.1 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $102.53 | -$51.5 | -$34.97 | $101.75 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.08 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |